Home > Browse Issues > Vol.35 No.4
Lipoxins and Liver Diseases
Yan Dan1#, Zhou Xiaoyan2#, Min Weiping3,4*
1Medical College of Nanchang University, Department of Pharmacology, Nanchang 330006, China;
2Medical College of Nanchang University, Department of Pathophysiology, Nanchang 330006, China;
3 Medical College of Nancha
2Medical College of Nanchang University, Department of Pathophysiology, Nanchang 330006, China;
3 Medical College of Nancha
Abstract: Lipoxins (LXs)， metabolites of arachidonic acid， are one of the most important endogenous lipid mediators which initiate inhibition inflammatory reaction as well as promote extinction of inflammation resolution.Nowadays， many advancements have been achieved in the research of their biosynthetic pathways， biological functions and effects in hepatic diseases. This article will review the progress in the related research.
CN
EN